CDT EQUITY INC. Operating Lease Right-of-Use Assets
CDT EQUITY INC. (CDT) had Operating Lease Right-of-Use Assets of $64.00 thousand as of 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-09-08
- 2026-06-30: Operating Lease, Right-of-Use Asset $64.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $109.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $142.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $194.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $64.00K S-1 · filed 2026-09-08 |
| 2026-03-31 | $109.00K 10-Q · filed 2026-07-15 |
| 2025-12-31 | $142.00K S-1 · filed 2026-09-08 |
| 2025-09-30 | $194.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $204.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $234.00K 10-Q/A · filed 2025-08-14 |
| 2024-12-31 | $263.00K S-1 · filed 2026-09-08 |
| 2024-09-30 | $292.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $319.00K 10-Q/A · filed 2024-11-14 |
| 2024-03-31 | $346.00K 10-Q/A · filed 2024-11-14 |
| 2024-03-07 | $400.00K S-1 · filed 2026-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |